Ipca Laboratories Limited (NSE:IPCALAB)
India · Delayed Price · Currency is INR 1,585.80
+42.20 (2.73%)
Jun 19, 2026, 3:30 PM IST
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 402.32 billion as of June 18, 2026. Its market cap has increased by 11.30% in one year.
Market Cap
402.32B
Enterprise Value
413.03B
Revenue
96.46B
Ranking
n/a
PE Ratio
35.26
Stock Price
1,585.80
Market Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 402.32B, an increase of 12,399.39%. That is a compound annual growth rate of 22.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 402.32B | 11.76% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurobindo Pharma | 818.42B |
| Laurus Labs | 739.50B |
| Alkem Laboratories | 639.37B |
| Glenmark Pharmaceuticals | 602.95B |
| Ajanta Pharma | 384.58B |
| Gland Pharma | 362.07B |
| Wockhardt | 328.69B |
| Emcure Pharmaceuticals | 327.17B |